🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For FreeCopy Portfolio

Ex-director accuses American Diabetes Association of 'pay to play' with sweetener Splenda

Published 11/15/2023, 03:11 PM
Updated 11/16/2023, 11:35 AM
BAYRY
-

By Brendan Pierson

(Reuters) -A former director of nutrition for the American Diabetes Association (ADA) sued the non-profit organization on Wednesday, accusing it of firing her for objecting to what she called a "pay to play" scheme to promote the no-calorie sweetener Splenda.

Elizabeth Hanna said the ADA "sold the good name of the organization" to sponsors like Splenda maker Heartland Food Products Group, "in violation of its own guidelines and standards of care on nutrition," in a lawsuit filed in state court in Bergen County, New Jersey.

Hanna specifically accused ADA Vice President Nicole Johnson of engaging in an "intentional and targeted campaign" of retaliation.

"The American Diabetes Association and Ms. Johnson deny all allegations put forth by Ms. Hanna and her lawyers, and we will respond further to Ms. Hanna's unfounded allegations in court at the appropriate time," a spokesperson for the ADA said in an email.

A Heartland spokesperson called the allegation that it was involved in a scheme "false and offensive."

The ADA describes its mission as educating the public about diabetes and lists several corporate sponsors, including Splenda, on its website. In its 2022 annual report, the ADA said Splenda was one of a group of "elite" supporters that had given more than $1 million, along with Bayer (OTC:BAYRY) Healthcare, Blue Cross Blue Shield of Illinois, Helmsley Charitable Trust and others.

On its website, Splenda publishes "diabetes-friendly recipes," endorsed by the ADA. Hanna, a registered dietitian nutritionist, said she refused to approve the endorsement of several of these recipes in July.

For example, Hanna said, one of the recipes was a cucumber salad containing 1/3 cup of Splenda sweetener. Hanna said she did not believe this met ADA nutrition guidelines.

"In short, there is no reason (other than taking Splenda's money) for the ADA to recommend that people with diabetes add massive amounts of Splenda to cucumber salad," she said.

Hanna said Johnson pressured her to approve the recipes despite her misgivings, prompting Hanna to complain to the ADA's human resources department. She said that human resources removed Johnson's ability to review Hanna, but that Johnson continued to complain about her within the organization.

Hanna's complaint cited recent studies suggesting that artificial sweeteners may cause cancer, elevated blood sugar and even diabetes. The U.S. Centers for Disease Control and Prevention states on its website that some studies have found possible health risks associated with the sweeteners, but that more research is needed.

In October, Hanna said, she was fired for pretextual reasons. She is accusing ADA of violating New Jersey law protecting employees from retaliation, and seeking unspecified money damages.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.